Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines. (2022)

First Author: Elliott T

Attributed to: saRNA SARS-CoV-2 vaccine funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1010885

PubMed Identifier: 36194628

Publication URI: http://europepmc.org/abstract/MED/36194628

Type: Journal Article/Review

Volume: 18

Parent Publication: PLoS pathogens

Issue: 10

ISSN: 1553-7366